|Day Low/High||4.52 / 4.70|
|52 Wk Low/High||3.50 / 4.70|
We beat the benchmark Russell 2000 for the quarter, and we await a busy week on the economic front.
Without proper collaboration tools and processes, loss of institutional knowledge may become rampant; likely costing companies millions due to productivity loss
We are keeping an eye on rate-sensitive names for possible buying opportunities, as stocks fell around 1.5% this week.
Jive advances its security environment for customers across government and other highly regulated industries
We picked up more Abraxas Petroleum on weakness, while the market rebounded slightly after the FOMC announced the anticipated quarter-point rate hike.
We bulked up on Abraxas Petroleum and Yamana Gold on weakness, as the markets pulled back and investors positioned for next week’s FOMC meeting.
Speakers will include social scientist Dacher Keltner and NASA astronaut Mark Kelly, as well as executives from Commvault, New Relic and Western Digital in Las Vegas May 1-3, 2017
We booked some profits in Huntington Bancshares and Builders FirstSource, while markets digested the likelihood of a March rate hike.
March 2 webinar to explore how a central hub for employee collaboration addresses the increasingly common challenge of disparate systems
We opened a new position in Abraxas Petroleum on its above-average growth potential, as stocks faced selling pressure this week.
We closed out our position in OraSure Technologies for an average gain of 105% gain.
The stock is up nearly 11% after management delivered better-than-expected quarterly results.
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
Experton Group ranks Jive a leader for portfolio attractiveness and market position
We used a price decline to add to our position in TherapeuticsMD this week.
Leading workplace interiors dealership unifies and energizes its distributed field employees with Jive
This week we'll get regional economic and housing data, a GDP report plus fourth-quarter earnings.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.